Clinical Trial Update: A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248 [NA]

View source ↗

Summary

Expanded access protocol for SU011248 in patients with metastatic renal cell carcinoma who are ineligible for participation in other SU011248 trials. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• SU011248

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Metastatic Renal Cell Carcinoma | NA | Status: COMPLETED